Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation.

Journal of medical Internet research·2026
Same author

Network-based near-scalp personalized brain stimulation targets.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

From outback to operating room: aeromedical retrieval and management of open-fracture trauma patients in Western Australia.

Rural and remote health·2026
Same author

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Nature communications·2026
Same author

Prolonged aldosterone suppression and renin upregulation after baxdrostat.

Journal of hypertension·2026
Same author

The great balancing debate: a history of observing and cultivating herd immunity, 1920-2020.

Medical history·2025

Related Experiment Video

Updated: Jun 3, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Neurocognitive function in dopamine-β-hydroxylase deficiency.

Marieke Jepma1, Jaap Deinum, Christopher L Asplund

  • 1Leiden University, Institute of Psychology, Leiden, The Netherlands. mjepma@fsw.leidenuniv.nl

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|April 8, 2011
PubMed
Summary
This summary is machine-generated.

Dopamine-β-hydroxylase deficiency, lacking norepinephrine, surprisingly shows largely intact cognitive function. This suggests other brain chemicals compensate for the absence of norepinephrine in patients.

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
11:26

Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake

Published on: September 21, 2017

Area of Science:

  • Neuroscience
  • Genetics
  • Psychology

Background:

  • Dopamine-β-hydroxylase (DβH) deficiency is a rare genetic disorder.
  • It results in the absence of norepinephrine, a key neurotransmitter, impacting both physical and neurological functions.
  • Despite norepinephrine's crucial role in cognition, DβH-deficient patients appear to have normal cognitive abilities.

Purpose of the Study:

  • To systematically investigate neurocognitive function in individuals with DβH deficiency.
  • To explore the impact of norepinephrine absence on cognitive performance, pupil dynamics, brain structure, and electroencephalogram (EEG) P3 component.
  • To compare DβH-deficient patients (on and off medication) with healthy controls.

Main Methods:

  • A comprehensive cognitive task battery was administered to 5 DβH-deficient patients and 10 healthy controls.
  • Pupil dynamics, brain structure (MRI), and EEG P3 component were analyzed.
  • Patients were tested both on and off L-threo-3,4-dihydroxyphenylserine medication.

Main Results:

  • DβH-deficient patients exhibited smaller total brain volume compared to controls.
  • Task-evoked pupil dilation was significantly reduced or absent in patients.
  • Cognitive performance and P3 amplitude were largely similar, except for a temporal-attention deficit in patients off medication.

Conclusions:

  • Norepinephrine may play a neurotrophic role, as indicated by reduced brain volume in DβH deficiency.
  • Despite norepinephrine absence, cognitive functions are largely preserved, suggesting compensatory mechanisms by other neuromodulators.
  • Further research is needed to fully understand the neurobiological adaptations in DβH deficiency.